Anti-PSP was the most frequently detected novel autoantibody in patients with primary SS (6/8, 75%), while anti-CA6 was the most commonly detected novel autoantibody in patients with other autoimmune diseases (5/10, 50%) and with no known autoimmune diseases (21/37, 57%). The gene discussed is BPIFA2; the disease is autoimmune disease.